18 November 2026 Events @ No 6, 6 Alie Street, London E1 8QT, UK
The HealthAI Global Governance Forum – Scaling Responsible AI in Health: From Trust to Implementation

Introduction

The HealthAI Global Governance Forum brings together the people shaping AI in health to turn shared principles into practical, inclusive and globally relevant governance action.

In 2026, participants from across government, health systems, academia, industry, civil society and communities will come together in London to explore how responsible AI can be governed, adopted and scaled safely, equitably and effectively in real health systems.

Through practical discussion, shared learning and collaboration, participants will help shape approaches that move responsible AI from trust to implementation.

About the Forum

The Global Governance Forum (HealthAI GGF) is our annual flagship event for the global community working at the intersection of health, responsible AI and governance.

The inaugural Forum took place in Nairobi in 2025. More than 240 participants joined across in-person and virtual formats, representing more than 50 countries. Policymakers, regulators, international organizations, industry, academia, civil society and young people contributed to an inclusive, cross-sector dialogue.

The 2025 program explored trust as a foundation for responsible AI in health. Keynotes, panels and workshops addressed regulatory oversight, health data governance and implementation in diverse contexts, with particular attention to the priorities of low- and middle-income countries.

In 2026, the Forum will build on this foundation by focusing on the policies, capabilities, infrastructure and partnerships needed to move responsible AI from principle to practice.

Column Image 2
What to Expect in 2026

What to Expect in 2026

A focused, 1-day program
Keynotes · Panels · Workshops
In-person networking session

Our 2026 Program

This year’s program will reflect a global dialogue, drawing on experience from different regions, institutions and health systems.

Your browser doesn't support PDFs. Please download the document instead. Download

Opening Plenary: Scaling Responsible AI in Health: A Call for Collective Action

1h15m | Plenary

HealthAI GGF 2026 will open with keynote speakers, setting the scene for this year’s Forum and highlighting key challenges and opportunities in scaling responsible AI for health. A GRN panel discussion will then bring members’ reflections to the forefront, followed by the beta launch of HealthAI’s Global Public Directory, a new resource showcasing registered AI solutions in healthcare across selected GRN countries. Together, the session will set the tone for the Forum while introducing one of HealthAI’s key initiatives to the wider public.

Keynote Speakers:

  • Dr Ricardo Baptista Leite –  CEO, HealthAI
  • Dr Jennifer Dixon – CEO, The Health Foundation
  • Mr Lawrence Tallon – CEO, Medicines and Healthcare products Regulatory Agency (MHRA)

GRN Panel Discussion:

  • Government representatives from Singapore, India, Zambia, Vietnam, Peru
  • Global Public Directory Soft Launch

Global Public Directory Beta Launch

  • Mr. Rado Andrian, Director of AI, HealthAI

Session 1: Breaking down Silos, One Debate at a Time

30m | Panel

Evaluating AI in healthcare requires contributions from developers, clinicians, regulators, health technology assessment bodies, healthcare leaders, researchers, program evaluators and communities. Yet, these groups often work in silos, assess different stages of the AI lifecycle and use the same terms in different ways. 

The HealthAI’s Working Group on AI Evaluation and Validation in Healthcare have used structured debate to examine terms, including “human-in-the-loop,” “performance metric,” and “clinical evaluation.” Each term is considered from five perspectives: manufacturer or developer, regulator, policymaker or health-system decision-maker, clinician, and program evaluator. This process delineates how meanings, priorities, and assumptions shift across roles and contexts. The aim is not always to produce a single universal definition, but to tease out nuances and build a shared understanding.

This work complements global initiatives such as the International Organization for Standardization (ISO)’s work on Terminology and Concepts for AI in Health. The session will use an interactive example to show how shared language can help bridge silos, strengthen evidence and support more comprehensive and context-sensitive evaluation.

Participating Organisations:

  • Vitus Consulting, Spain
  • OECD, France
  • Vital Strategies, South Africa

Thematic Area: Strengthening Human Awareness and Literacy for Responsible AI in Health

Session 2: From Ambition to Action: How are Governments Approaching AI in Health?

1h15m | Panel

AI presents governments with both an opportunity and a challenge: how to move beyond experimentation and make informed choices about where, how and at what scale it can improve health systems. This session brings together practical experiences from national, regional and health-system levels, exploring how governments can prioritise AI use cases, evaluate and procure solutions, build effective governance, develop workforce capacity and collaborate across borders. Short presentations will set the scene, and be accompanied by a panel discussion with all 4 presenters on how governments should approach the procurement of AI solutions for their health systems.

Participating Organisations:

  • Tony Blair Institute for Global Change, UK
  • Government of Andhra Pradesh, India
  • ORAS-CONHU, Peru
  • Emirates Health Services, UAE

Thematic area: Making AI Governance Principles and Frameworks Work in Practice

Session 3: Walk the Talk: Designing Engagement That Works

1h15m | Workshop

Meaningful multi-stakeholder engagement is essential to building trusted, accountable and responsible AI. The session explores approaches to embedding patient voices through a Patient Engagement in Digital Health Roadmap, and strengthening accountability throughout the total product lifecycle across various stakeholder groups. Two short presentations will be followed by an interactive AI Governance and Readiness Walk addressing practical realities such as accountability, human review and appeal mechanisms, leadership support, explainability, fairness and confidence in challenging AI recommendations. As participants move, the room becomes a visual representation of different governance and readiness positions, allowing us to to identify practical enablers for collaborative AI governance.

This session will include:

  • Patient Focused Medicines Development (PFMD), Belgium
  • Project Concern International (PCI), India
  • Swiss TPH, Switzerland

Thematic area: Meaningful Multi-Stakeholder Engagement to Advance Trust in AI in Health

Session 4: What Makes Scale Possible? Responsible AI Innovation in Practice

1h15m | Flash Talks

Moving an AI innovation from a promising pilot to sustainable impact requires more than technical performance. This session explores the practical drivers of responsible scaling, including contextual evidence, sustainable infrastructure and financing, workforce readiness, trust and engagement, governance, and integration into real-world workflows. Drawing on examples from Africa, Asia, Europe and beyond, the session will examine what enables innovations to move from experimentation to safe, trusted and sustainable adoption. Blocks of short talks will be accompanied by fireside chats with the innovators to extract out enablers and challenges of scaling AI innovation in health. The audience will also be engaged to provide their reflections through a digital platform.

Participating Organisations:

  • The South African Consortium of Air Quality Monitoring, South Africa
  • Nordic Wellbeing Academy, Denmark
  • Qure.ai, India
  • Makerere AI Health Lab, Uganda
  • Visual Thinking, Portugal
  • Johnson & Johnson, USA

Thematic area: Drivers for Scaling Responsible AI Innovation in Health

Session 5: After Go-Live: Monitoring AI in the Real World

1h15m | Workshop

As AI moves into real-world clinical settings, effective monitoring is essential to ensure that systems remain safe, effective and fit for purpose over time. This interactive workshop introduces different approaches to AI monitoring, followed by a role-play in which participants design a monitoring system for a large, multi-site healthcare organisation. The session concludes with a real-world case study from Tandem Health, illustrating post-market surveillance and monitoring of its Ambient Voice Transcription (AVT) technology in practice.

Participating Organisations:

  • CERSI-AI, UK
  • Tandem Health, Sweden

Thematic area: Making AI Governance Principles and Frameworks Work in Practice

Session 6: From Evidence to Market: Rapid Evaluation and Regulatory Innovation

1h10m | Panel

AI is challenging traditional approaches to regulatory decision-making and evidence generation, requiring health systems to find ways to assess technologies efficiently without compromising safety or trust. This session begins with a presentation from THF on opportunities for collaborative efforts to establish the evaluation architecture necessary for robust rapid real-world evaluation of AI applications in healthcare.  This will be followed by a panel discussion with regulators to explore regulatory innovation needed for increasingly autonomous AI systems, regulatory reliance for AI-enabled medical devices, as well as the use of AI for regulation. Together, the session will discuss how evaluation and regulatory pathways can evolve to support timely, evidence-informed adoption of AI.

Participating Organisations:

  • The Health Foundation, UK 
  •  HealthAI’s Global Regulatory Network

Thematic area: Making AI Governance Principles and Frameworks Work in Practice

Session 7: Who Decides? Who Answers? Sovereignty, Rights and Accountability

1h10m | Fishbowl Discussion

As AI becomes increasingly embedded across sectors and borders, questions of sovereignty, control and accountability are becoming ever more important. Who should shape AI, who holds decision-making power, and who is ultimately accountable for its impacts are questions increasingly being asked by our societies. Following a grounding presentation, this fishbowl discussion will start off by unpacking terms such as sovereignty, rights and accountability, before exploring topics on digital resilience, data provenance, consent, collective authority, privacy requirements, contestability, and redress. The aim will be to bring diverse perspectives into an open and participatory debate and distill key emerging themes.

Participating Organisations:

  • Nottingham Trent University, UK
  • Transform Health, Switzerland
  • Government of Oman
  • Government of Estonia
  • Makerere University Walter Reed Program, Uganda

Thematic area: Navigating AI, Data, and Digital Sovereignty in Health

Session 8: Building AI Literacy in Health: What Does it Mean in Practice?

1h10m | Workshop

AI is rapidly transforming healthcare, strengthening AI awareness and literacy becomes essential for safe, equitable and responsible adoption. This session begins by showcasing the development of a competency- based curriculum for Responsible AI in health for low-resource settings, through an evidence synthesis and participatory co-design methodology, for health system actors. This is then followed by a presentation of the Modular and Stratified Healthcare AI Literacy Framework (M-SHALF), developed by Harvard Law School for healthcare organizations to implement role-specific AI literacy programs. The session concludes with an interactive workshop demonstrating how AI literacy can be gained through a conversational learning experience.

Participating Organisations:

 

  • Harvard Law School, USA 
  • Romion Health, The Netherlands

Thematic area: Strengthening Human Awareness and Literacy for Responsible AI in Health

Session 9: From Authorization to Access: Health Technology Assessment for AI in Health

1h15m | Panel

Health technology assessment (HTA) can play a critical role in helping health systems determine whether AI technologies deliver meaningful value and under what conditions they should be adopted. This session brings together country experiences from ACE, NICE and NHRDC, followed by a short panel exploring how different health systems are adapting HTA approaches for AI. The session will then soft-launch HealthAI’s HTA Blueprint, followed by a fireside chat with HTAi on the future of HTA for AI and how global approaches can support evidence-informed, responsible adoption, including in low-resource settings.

Participating Organisations:

  • LATAM HTA, Colombia
  • NICE, UK
  • NHRDC, People’s Republic of China
  • HealthAI, Switzerland
  • HTAi, Canada

Thematic area: Making AI Governance Principles and Frameworks Work in Practice

Session 10: From Global AI in Health Action Plan to Regional Practice

1h15m | Panel

Responsible AI principles are increasingly well established, but translating them into coordinated action remains a challenge for countries and health systems. This interactive panel session explores how international alignment and regional collaboration can help bridge the gap between guidance and implementation, drawing on the Expert-led Madrid Action Plan (EL-MAP) and the experience of regional digital health networks across Asia, Africa, the Pacific and Latin America and the Caribbean. Through facilitated dialogue, live polling and cross-regional perspectives, participants will help identify practical priorities, implementation needs and opportunities for stronger collaboration to enable safe, equitable and sustainable AI at scale.

Participating Organisations:

  • OECD, France
  • CHAI, USA
  • The Health Foundation, UK
  • RECAINSA, Guatemala
  • Global Digital Health Network (GDHN), USA
  • Asia eHealth Information Network (AeHIN), India
  • Pan African Health Informatics Association (HELINA), Tanzania
  • Pacific Health Information Network (PHIN), Samoa

Thematic area: Making AI Governance Principles and Frameworks Work in Practice

Session 11: Trust in Practice: Who Gets a Voice?

1h15m | Panel

AI is increasingly becoming part of how people enter, navigate and experience healthcare, challenging traditional approaches to health system governance. This interactive panel will explore what it means to reframe the patient journey as a practical unit of governance, bringing together perspectives on trust, accountability, community readiness and shared responsibility. The discussion will move from the overarching governance challenge to practical examples from Nigeria, India and Bangladesh, examining what can be learned from different social and cultural contexts, and how health systems can build trust through governance approaches that are inclusive, adaptive and fit for purpose.

Participating Organisations:

  • The University of Alabama, USA
  • Baraka Finance Institute, Portugal
  • Movement Health, Denmark
  • Call Off Cancer Initiative, Nigeria
  • Centre for Sustainable Health Innovations, Public Health Foundation, India

Thematic area: Meaningful Multi-Stakeholder Engagement to Advance Trust in AI in Health

Closing Session: Governance Pulse

45m | Closing

The Health Foundation has conducted UK national polling and deliberative research on public attitudes to technology and AI as part of the National Commission into the Regulation of AI in Healthcare. Polling has suggested that the public recognizes the potential benefits of AI in healthcare but expect cereal safeguards around its use. Public trust and confidence will depend not simply on what people think of the technology itself but whether it has been introduced safely, fairly and in an accountable manner. Ultimately safety, effectiveness and accountability matter the most. With our Forum participants, selected questions from the national polling will presented to them to seek their opinions throughout the day. The results of the Forum poll will be presented side by side the national poll findings as THF presents their work.

Participating Organisations:

  • The Health Foundation
  • HealthAI

Beyond the Room: HealthAI GGF Abstract Digital Showcase

Not every important idea can fit into the live program. Beyond the Room extends the Forum by giving selected abstracts a dedicated digital space to be discovered, shared and explored.

Featured contributors will create a concise digital profile of their work, including the abstract title, a short summary, a key takeaway and a short video. Delegates will be able to explore the showcase during and after the Forum, creating more opportunities for strong ideas to reach new audiences and spark further conversation.

The showcase will also help carry learning beyond the event itself, feeding into post-Forum outputs and HealthAI’s wider Community of Practice.

Because the conversation should not end when the session does.

Speakers at HealthAI GGF 2026

Ahmed Binesmael

Ahmed leads the Health Foundation’s research exploring public and staff attitudes towards AI, technology and data use in health care, with a broader interest in how existing and emerging technologies can be implemented responsibly and effectively to improve care, support patients and staff, and inform health policy and wider system transformation. Prior to joining the Health Foundation, Ahmed was a Senior Policy Adviser at the British Medical Association, where he developed costed policy proposals aimed at influencing government policy and supporting doctor-led health policy initiatives, including modelling the cost of pay restoration for doctors. His wider research and analysis have also contributed to policy work across digital infrastructure, pensions, public health, general practice, and long COVID.

View Bio
Ahmed Binesmael

Ahmed Binesmael

close

Ahmed leads the Health Foundation’s research exploring public and staff attitudes towards AI, technology and data use in health care, with a broader interest in how existing and emerging technologies can be implemented responsibly and effectively to improve care, support patients and staff, and inform health policy and wider system transformation. Prior to joining the Health Foundation, Ahmed was a Senior Policy Adviser at the British Medical Association, where he developed costed policy proposals aimed at influencing government policy and supporting doctor-led health policy initiatives, including modelling the cost of pay restoration for doctors. His wider research and analysis have also contributed to policy work across digital infrastructure, pensions, public health, general practice, and long COVID.

Bogi Eliasen

Bogi Eliasen is the CEO of Movement Health Foundation and a Fellow at the Copenhagen Institute for Futures Studies. An award-winning futurist and global health advisor, he has spent two decades bridging health, policy, and technology, with recognized thought leadership in genomics, data, and digital health. He initiated FarGen, the first population genome-sequencing project in the Faroe Islands, and led the Nordic Health 2030 process. He is Co-Chair of the WHO Strategic Partners’ Initiative for Data and Digital Health, Richard von Weizsäcker Fellow at the Robert Bosch Academy, and strategic advisor to the World Economic Forum and the World Bank.

View Bio
Bogi Eliasen

Bogi Eliasen

close

Bogi Eliasen is the CEO of Movement Health Foundation and a Fellow at the Copenhagen Institute for Futures Studies. An award-winning futurist and global health advisor, he has spent two decades bridging health, policy, and technology, with recognized thought leadership in genomics, data, and digital health. He initiated FarGen, the first population genome-sequencing project in the Faroe Islands, and led the Nordic Health 2030 process. He is Co-Chair of the WHO Strategic Partners’ Initiative for Data and Digital Health, Richard von Weizsäcker Fellow at the Robert Bosch Academy, and strategic advisor to the World Economic Forum and the World Bank.

Bruce Mellado

Bruce Mellado PhD (Columbia University) has been recognized with prestigious awards, including the TW Kambule-NSTF Prize for Research (2021) and Innovation (2026), the Vice-Chancellor’s Prize for Research (2022) and innovation (2025), the ODESS2025 Prize from the Pierre Fabre Foundation (2025). He is a Fellow of both the African and South African Academies of Sciences. He was an advisor to Gauteng Premier during the Covid-19 pandemic. He is the Co-Executive Director of the Africa-Canada Artificial Intelligence Data Modelling Consortium, the Executive Director of the South African Consortium for Air Quality Monitoring and the inventor of the AI_r technology.

View Bio
Bruce Mellado

Bruce Mellado

close

Bruce Mellado PhD (Columbia University) has been recognized with prestigious awards, including the TW Kambule-NSTF Prize for Research (2021) and Innovation (2026), the Vice-Chancellor’s Prize for Research (2022) and innovation (2025), the ODESS2025 Prize from the Pierre Fabre Foundation (2025). He is a Fellow of both the African and South African Academies of Sciences. He was an advisor to Gauteng Premier during the Covid-19 pandemic. He is the Co-Executive Director of the Africa-Canada Artificial Intelligence Data Modelling Consortium, the Executive Director of the South African Consortium for Air Quality Monitoring and the inventor of the AI_r technology.

Christoph Benn

Christoph Benn is currently serving as Executive Director of the Center for Global Health Diplomacy in Geneva, working at the intersection of global health, development, economics, finance, politics and the climate change. He has been a member of the founding board at the creation of the Global Fund to fight AIDS, Tuberculosis and Malaria in 2002. Under his leadership the Global Fund has mobilized pledges and contributions of more than USD 50 billion. Christoph has served as advisor to many international organizations including WHO, UNDP, The Green Climate Fund, the World Bank, CEPI and FIND. Prior to joining the Global Fund, Christoph worked as a clinician and public health specialist in the United Kingdom, Germany and as Doctor-in-Charge of a rural hospital in Tanzania. He has more than 30 years of experience in global health with a special focus on infectious diseases, having worked as an advisor to many public health programs in eastern Europe, Africa and Asia. Christoph currently serves as Special Advisor to Africa CDC, Chair of the Board of HealthAI, Chair of the Asia Pacific Leaders Malaria Alliance (APLMA), Co-Chair of the steering committee of the Global Health Hub Germany, President of the Transform Health coalition and as board member of Friends of the Global Fund Europe.

View Bio
Christoph Benn

Christoph Benn

close

Christoph Benn is currently serving as Executive Director of the Center for Global Health Diplomacy in Geneva, working at the intersection of global health, development, economics, finance, politics and the climate change.

He has been a member of the founding board at the creation of the Global Fund to fight AIDS, Tuberculosis and Malaria in 2002. Under his leadership the Global Fund has mobilized pledges and contributions of more than USD 50 billion.

Christoph has served as advisor to many international organizations including WHO, UNDP, The Green Climate Fund, the World Bank, CEPI and FIND.
Prior to joining the Global Fund, Christoph worked as a clinician and public health specialist in the United Kingdom, Germany and as Doctor-in-Charge of a rural hospital in Tanzania. He has more than 30 years of experience in global health with a special focus on infectious diseases, having worked as an advisor to many public health programs in eastern Europe, Africa and Asia.

Christoph currently serves as Special Advisor to Africa CDC, Chair of the Board of HealthAI, Chair of the Asia Pacific Leaders Malaria Alliance (APLMA), Co-Chair of the steering committee of the Global Health Hub Germany, President of the Transform Health coalition and as board member of Friends of the Global Fund Europe.

David J. Lowe

David J. Lowe is Clinical Director of Innovation at the University of Glasgow, Emergency Consultant at Queen Elizabeth University Hospital, and Clinical Lead for Innovation for the Scottish Government. With extensive experience fostering innovation in healthcare, he collaborates with academic and industry partners globally to develop cutting-edge devices, services, and solutions. He has led AI-focused initiatives as lead for the Digital Health Validation Lab, including applications in COVID-19, osteoporosis, and the development of AI solutions across a range of imaging modalities including echo, CT and X-Ray. David directs programmes implementing and evaluation technologies within clinical pathways focused on system redesign focusing on diagnostics and long term condition management. He is a founding member of the Centre of Excellence for Regulatory Science- AI, part of UK Commission for AI Regulation in Heath and on the board for MHRA Airlock. Areas of focus are COPD, HF and lung cancer embedding new medtech and specifically AI solutions to support case-finding, diagnosis and prioritisation.

View Bio
David J. Lowe

David J. Lowe

close

David J. Lowe is Clinical Director of Innovation at the University of Glasgow, Emergency Consultant at Queen Elizabeth University Hospital, and Clinical Lead for Innovation for the Scottish Government. With extensive experience fostering innovation in healthcare, he collaborates with academic and industry partners globally to develop cutting-edge devices, services, and solutions. He has led AI-focused initiatives as lead for the Digital Health Validation Lab, including applications in COVID-19, osteoporosis, and the development of AI solutions across a range of imaging modalities including echo, CT and X-Ray. David directs programmes implementing and evaluation technologies within clinical pathways focused on system redesign focusing on diagnostics and long term condition management. He is a founding member of the Centre of Excellence for Regulatory Science- AI, part of UK Commission for AI Regulation in Heath and on the board for MHRA Airlock. Areas of focus are COPD, HF and lung cancer embedding new medtech and specifically AI solutions to support case-finding, diagnosis and prioritisation.

Eric Sutherland

Eric is a Senior Health Economist leading the OECD’s work in Digitalisation of Health, bringing together policy guidance for digital security, integrated data, and responsible analytics including artificial intelligence. In that role, he is accountable for measuring and evolving the OECD’s Recommendation on Health Data Governance (2016) and supporting policy for digitalisation of health that provides data protection (e.g. security and privacy) and timely access to quality data to optimize the use of data for information, insights, and impact among individuals, health workers, policy makers, researchers, and innovators.

View Bio
Eric Sutherland

Eric Sutherland

close

Eric is a Senior Health Economist leading the OECD’s work in Digitalisation of Health, bringing together policy guidance for digital security, integrated data, and responsible analytics including artificial intelligence. In that role, he is accountable for measuring and evolving the OECD’s Recommendation on Health Data Governance (2016) and supporting policy for digitalisation of health that provides data protection (e.g. security and privacy) and timely access to quality data to optimize the use of data for information, insights, and impact among individuals, health workers, policy makers, researchers, and innovators.

Estela Bastos

Estela Bastos is CEO of Visual Thinking and President of CIIASM – Centre for Research and AI applied in Mental Health. Her work focuses on the responsible adoption of AI in healthcare, bridging technology, clinical practice, data governance, regulatory requirements and real-world implementation. She leads and contributes to initiatives involving the development, deployment and clinical evaluation of AI-enabled solutions in healthcare settings, with a particular focus on responsible AI, human oversight, privacy, safety and scalable implementation within public healthcare systems.

View Bio
Estela Bastos

Estela Bastos

close

Estela Bastos is CEO of Visual Thinking and President of CIIASM – Centre for Research and AI applied in Mental Health. Her work focuses on the responsible adoption of AI in healthcare, bridging technology, clinical practice, data governance, regulatory requirements and real-world implementation. She leads and contributes to initiatives involving the development, deployment and clinical evaluation of AI-enabled solutions in healthcare settings, with a particular focus on responsible AI, human oversight, privacy, safety and scalable implementation within public healthcare systems.

Innocent Chiboma

Innocent Chiboma is a seasoned Digital Health Expert with over 20 years of transformative work in Zambia’s digital health landscape. He holds a BSc (Hons) in Computing and an MBA in Technology Management, seamlessly blending technical know-how with strategic foresight. At the Ministry of Health, Innocent has played a pivotal role in implementing systems like the National Electronic Health Record System (SmartCare), the Laboratory Information System (DISALAB*), and the Electronic Logistics Information System (eLMIS), significantly advancing data management and patient care across the country. In addition to leading the development of Zambia’s 2022-2026 Digital Health Strategy and the Health Data Governance Framework, he spearheaded the reorganization of the Digital Health Technical Working Group. As Principal ICT Officer for Digital Health, has unwavering commitment to innovation and his global contributions position him as a transformative figure in digital health.

View Bio
Innocent Chiboma

Innocent Chiboma

close

Innocent Chiboma is a seasoned Digital Health Expert with over 20 years of transformative work in Zambia’s digital health landscape. He holds a BSc (Hons) in Computing and an MBA in Technology Management, seamlessly blending technical know-how with strategic foresight. At the Ministry of Health, Innocent has played a pivotal role in implementing systems like the National Electronic Health Record System (SmartCare), the Laboratory Information System (DISALAB*), and the Electronic Logistics Information System (eLMIS), significantly advancing data management and patient care across the country.

In addition to leading the development of Zambia’s 2022-2026 Digital Health Strategy and the Health Data Governance Framework, he spearheaded the reorganization of the Digital Health Technical Working Group. As Principal ICT Officer for Digital Health, has unwavering commitment to innovation and his global contributions position him as a transformative figure in digital health.

Iran Cartaxo

Iran Cartaxo is a Mechanical engineer, Master in public health from FIOCRUZ with the dissertation “Applications as medical devices: Is there risk at your fingertips?”. He has 25 years of experience in the health area and 12 years in the area of regulation of health equipment with ANVISA. He was mainly responsible for the process that led to the publication of the resolution of 2022 which provides for the regularization of software as a medical device in Brazil. Specialist in Regulation and Health Surveillance – Equipment Technology Management – GQUIP/GGTPS/ANVISA.

View Bio
Iran Cartaxo

Iran Cartaxo

close

Iran Cartaxo is a Mechanical engineer, Master in public health from FIOCRUZ with the dissertation “Applications as medical devices: Is there risk at your fingertips?”. He has 25 years of experience in the health area and 12 years in the area of regulation of health equipment with ANVISA. He was mainly responsible for the process that led to the publication of the resolution of 2022 which provides for the regularization of software as a medical device in Brazil. Specialist in Regulation and Health Surveillance – Equipment Technology Management – GQUIP/GGTPS/ANVISA.

Jai Ganesh Udayasankaran

Jai Ganesh Udayasankaran (Jai) is the Executive Director of the Asia eHealth Information Network (AeHIN), with over 20 years of experience in digital health, including hospital information systems, telemedicine, and chronic disease management platforms. He serves on the Board of the Global Digital Health Network (GDHN) and contributes to several international and national standards bodies, including ISO and the Bureau of Indian Standards. He is also an adjunct faculty member at Manipal Academy of Higher Education (MAHE), India. Jai regularly supports convening digital health convergence workshops across South and South-East Asia and has contributed to various publications on digital health standards and practices.

View Bio
Jai Ganesh Udayasankaran

Jai Ganesh Udayasankaran

close

Jai Ganesh Udayasankaran (Jai) is the Executive Director of the Asia eHealth Information Network (AeHIN), with over 20 years of experience in digital health, including hospital information systems, telemedicine, and chronic disease management platforms. He serves on the Board of the Global Digital Health Network (GDHN) and contributes to several international and national standards bodies, including ISO and the Bureau of Indian Standards. He is also an adjunct faculty member at Manipal Academy of Higher Education (MAHE), India.

Jai regularly supports convening digital health convergence workshops across South and South-East Asia and has contributed to various publications on digital health standards and practices.

Joseline Carías – Galeano

Joseline Carías-Galeano is Executive Director of RECAINSA, a regional non-profit network advancing equitable digital health transformation across Latin America and the Caribbean. She leads regional and global initiatives in digital health governance, responsible artificial intelligence, workforce development, gender equity and multi-stakeholder collaboration. Her work connects governments, academia, civil society, professional communities, development partners and the private sector to translate global commitments into practical, country-led action. She has contributed to high-level forums including the World Health Assembly, World Health Summit, United Nations World Data Forum and Global Digital Health Forum, bringing a pragmatic, implementation-focused perspective from Latin America and the Caribbean.

View Bio
Joseline Carías - Galeano

Joseline Carías – Galeano

close

Joseline Carías-Galeano is Executive Director of RECAINSA, a regional non-profit network advancing equitable digital health transformation across Latin America and the Caribbean. She leads regional and global initiatives in digital health governance, responsible artificial intelligence, workforce development, gender equity and multi-stakeholder collaboration. Her work connects governments, academia, civil society, professional communities, development partners and the private sector to translate global commitments into practical, country-led action. She has contributed to high-level forums including the World Health Assembly, World Health Summit, United Nations World Data Forum and Global Digital Health Forum, bringing a pragmatic, implementation-focused perspective from Latin America and the Caribbean.

Kicky van Leeuwen

Kicky van Leeuwen is an expert in the practical and responsible deployment of AI in healthcare. She earned her PhD cum laude in radiology on the implementation of AI, then built extensive experience validating, procuring, and implementing commercial AI solutions in clinical practice, first at Radboudumc and later across various healthcare organisations. As co-founder of Romion Health, she advises healthcare organisations across Europe on strategic AI questions, from governance and regulation to product selection and practical implementation. She is also the initiator of the Health AI Register, an internationally used platform providing insight into medical CE-marked AI software.

View Bio
Kicky van Leeuwen

Kicky van Leeuwen

close

Kicky van Leeuwen is an expert in the practical and responsible deployment of AI in healthcare. She earned her PhD cum laude in radiology on the implementation of AI, then built extensive experience validating, procuring, and implementing commercial AI solutions in clinical practice, first at Radboudumc and later across various healthcare organisations. As co-founder of Romion Health, she advises healthcare organisations across Europe on strategic AI questions, from governance and regulation to product selection and practical implementation. She is also the initiator of the Health AI Register, an internationally used platform providing insight into medical CE-marked AI software.

Kieu Quang Tuan

Kieu Quang Tuan is a Specialist at the National Health Information Center (Ministry of Health of Vietnam), where he is responsible for AI in health research, health data, international cooperation, the Health Open Data Portal, and activities related to digital health transformation research and consultancy. Previously, he worked at the Center for IT Application in Health, under the Administration of Information Technology, Ministry of Health (2020–2023), and served as Head of the Research and Development Department from June 2023 to December 2024. He also held positions at the Health Insurance Appraisal and Payment Center of Vietnam Social Security (2017–2019) and the Health Insurance Department (2015–2017). Mr. Tuan holds a Bachelor’s degree in Economics and a Master’s degree in Economics–Finance (Academy of Finance), a Master’s degree in Health Financing Security & Management (Naresuan University, Thailand), and an Engineer’s degree in Information Technology (Hanoi University of Science and Technology). He has presented at forums such as ISPOR/HTAsiaLink and Digital Health, and has authored articles on HTA/health policy and digital health.

View Bio
Kieu Quang Tuan

Kieu Quang Tuan

close

Kieu Quang Tuan is a Specialist at the National Health Information Center (Ministry of Health of Vietnam), where he is responsible for AI in health research, health data, international cooperation, the Health Open Data Portal, and activities related to digital health transformation research and consultancy. Previously, he worked at the Center for IT Application in Health, under the Administration of Information Technology, Ministry of Health (2020–2023), and served as Head of the Research and Development Department from June 2023 to December 2024. He also held positions at the Health Insurance Appraisal and Payment Center of Vietnam Social Security (2017–2019) and the Health Insurance Department (2015–2017). Mr. Tuan holds a Bachelor’s degree in Economics and a Master’s degree in Economics–Finance (Academy of Finance), a Master’s degree in Health Financing Security & Management (Naresuan University, Thailand), and an Engineer’s degree in Information Technology (Hanoi University of Science and Technology). He has presented at forums such as ISPOR/HTAsiaLink and Digital Health, and has authored articles on HTA/health policy and digital health.

Konrad Samsel

Konrad is a Trainee Affiliate at the Temerty Centre for Artificial Intelligence (AI) Research and Education in Medicine and a PhD Student at the Institute of Health Policy, Management and Evaluation at the University of Toronto (Canada). His work focuses on the development, implementation, and governance of AI in healthcare, with interests in patient engagement, health equity, and health system transformation. He also serves as an Expert-in-Residence for the AMS-Fitzgerald Program, supporting Canadian health system leaders undertaking digital transformation projects. He works closely with health organizations and has overseen nine quality improvement and patient safety projects across Toronto’s hospital system.

View Bio
Konrad Samsel

Konrad Samsel

close

Konrad is a Trainee Affiliate at the Temerty Centre for Artificial Intelligence (AI) Research and Education in Medicine and a PhD Student at the Institute of Health Policy, Management and Evaluation at the University of Toronto (Canada). His work focuses on the development, implementation, and governance of AI in healthcare, with interests in patient engagement, health equity, and health system transformation. He also serves as an Expert-in-Residence for the AMS-Fitzgerald Program, supporting Canadian health system leaders undertaking digital transformation projects. He works closely with health organizations and has overseen nine quality improvement and patient safety projects across Toronto’s hospital system.

Lars Münter

Lars Münter is a Nordic public health strategist and NGO executive with more than two decades of experience shaping health policy across Europe. As Founder and International Director of Nordic Wellbeing Academy and Network Director of the European Health Futures Forum, he leads EU-funded initiatives spanning health literacy, digital health, and citizen empowerment. As advisor and ambassador for a number of European organisations and projects, Lars combines academic rigour with the practical credibility of someone who has built organisations, secured millions in European funding, and delivered programmes across 15+ countries.

View Bio
Lars Münter

Lars Münter

close

Lars Münter is a Nordic public health strategist and NGO executive with more than two decades of experience shaping health policy across Europe. As Founder and International Director of Nordic Wellbeing Academy and Network Director of the European Health Futures Forum, he leads EU-funded initiatives spanning health literacy, digital health, and citizen empowerment. As advisor and ambassador for a number of European organisations and projects, Lars combines academic rigour with the practical credibility of someone who has built organisations, secured millions in European funding, and delivered programmes across 15+ countries.

Lawrence Tallon

Lawrence Tallon is the Chief Executive of the Medicines and Healthcare products Regulatory Agency (MHRA). He was previously Deputy Chief Executive at Guy’s and St Thomas’ NHS Foundation Trust, where he led the Trust’s approach to strategy, technology, innovation and improvement. He has extensive experience across the healthcare sector in strategy and leadership roles, including within the Department of Health and Social Care alongside ministers and NHS leaders. Lawrence is committed to patient safety and healthcare innovation, as well as life sciences and risk-proportionate regulation.

View Bio
Lawrence Tallon

Lawrence Tallon

close

Lawrence Tallon is the Chief Executive of the
Medicines and Healthcare products Regulatory
Agency (MHRA). He was previously Deputy Chief
Executive at Guy’s and St Thomas’ NHS Foundation
Trust, where he led the Trust’s approach to strategy,
technology, innovation and improvement. He has
extensive experience across the healthcare sector in
strategy and leadership roles, including within the
Department of Health and Social Care alongside
ministers and NHS leaders.

Lawrence is committed to patient safety and
healthcare innovation, as well as life sciences and
risk-proportionate regulation.

Mazeda Hossain

Professor Mazeda Hossain is Professor of Global Health and Director of the Eastern Africa Centre at Nottingham Trent University. She leads interdisciplinary research at the intersection of global health, equity, gender, and data-driven policy. She has developed innovative measurement frameworks, including the Global Wellbeing & Resilience Index. Her current health-AI work focuses on ethical and inclusive AI governance, health-data privacy, and responsible AI for marginalised populations. She collaborates with governments, UN agencies, academia, and industry to advance equitable, trustworthy, and socially responsive AI in global health.

View Bio
Mazeda Hossain

Mazeda Hossain

close

Professor Mazeda Hossain is Professor of Global Health and Director of the Eastern Africa Centre at Nottingham Trent University. She leads interdisciplinary research at the intersection of global health, equity, gender, and data-driven policy. She has developed innovative measurement frameworks, including the Global Wellbeing & Resilience Index. Her current health-AI work focuses on ethical and inclusive AI governance, health-data privacy, and responsible AI for marginalised populations. She collaborates with governments, UN agencies, academia, and industry to advance equitable, trustworthy, and socially responsive AI in global health.

Mona Duggal

Dr Mona Duggal is a distinguished public health researcher and currently serves as Scientist-G & Director of the ICMR–National Institute for Research in Digital Health and Data Science (NIRDHDS), New Delhi. With extensive expertise in digital health, epidemiology, biomedical research, and maternal and child health, she has led pioneering initiatives to strengthen India’s capacity in data systems, clinical trial analytics, disease surveillance, and evidence-based policy translation. At NIRDHDS, Dr Duggal spearheads the institute’s vision “to drive impact on health by innovating, facilitating, and evaluating digital health solutions and ensuring responsible and inclusive/equitable health delivery for all”. The institute’s mission is built on a continuous adaptive learning framework where digital solutions and AI models are validated, monitored, and refined through real-world deployment. Its core priorities include building of data infrastructure, interdisciplinary collaboration, development of ethical AI protocols, innovation pilots, and actionable policy recommendations. Under Dr Duggal’s leadership, NIRDHDS is moving forward in patient-centred digital health innovation, fostering responsible AI adoption and positioning India at the forefront of global digital health transformation.

View Bio
Mona Duggal

Mona Duggal

close

Dr Mona Duggal is a distinguished public health researcher and currently serves as Scientist-G & Director of the ICMR–National Institute for Research in Digital Health and Data Science (NIRDHDS), New Delhi. With extensive expertise in digital health, epidemiology, biomedical research, and maternal and child health, she has led pioneering initiatives to strengthen India’s capacity in data systems, clinical trial analytics, disease surveillance, and evidence-based policy translation.

At NIRDHDS, Dr Duggal spearheads the institute’s vision “to drive impact on
health by innovating, facilitating, and evaluating digital health solutions and
ensuring responsible and inclusive/equitable health delivery for all”. The institute’s mission is built on a continuous adaptive learning framework where digital solutions and AI models are validated, monitored, and refined through real-world deployment. Its core priorities include building of data infrastructure, interdisciplinary collaboration, development of ethical AI protocols, innovation pilots, and actionable policy recommendations. Under Dr Duggal’s leadership, NIRDHDS is moving forward in patient-centred digital health innovation, fostering responsible AI adoption and positioning India at the forefront of global digital health transformation.

Ned Naylor

Dr Ned Naylor leads TBI’s health advisory work, helping governments across five continents deliver on their health priorities. His work focuses on health system reform, digital innovation and the application of AI in healthcare. Before joining TBI, Ned led strategy for England’s Covid-19 vaccination programme, supporting the delivery of tens of millions of vaccinations. He has held roles at McKinsey & Company and the UK NHS, and co-leads the Reimagining Health course at UCL Global Business School for Health. Ned holds a Master’s in Public Health and has practised as a doctor in the UK and South Africa.

View Bio
Ned Naylor

Ned Naylor

close

Dr Ned Naylor leads TBI’s health advisory work, helping governments across five continents deliver on their health priorities. His work focuses on health system reform, digital innovation and the application of AI in healthcare. Before joining TBI, Ned led strategy for England’s Covid-19 vaccination programme, supporting the delivery of tens of millions of vaccinations. He has held roles at McKinsey & Company and the UK NHS, and co-leads the Reimagining Health course at UCL Global Business School for Health. Ned holds a Master’s in Public Health and has practised as a doctor in the UK and South Africa.

Nishtha Mahendru

Nishtha Mahendru is Technical Consultant, AI Innovation at Project Concern International India, where she develops AI-enabled tools for infectious disease control. She holds an M.Tech in Biomedical Engineering from IIT Delhi. Previously, as Assistant Manager for Responsible AI & Strategy at MicroSave Consulting, she co-authored India’s National Responsible AI Development Framework and led the national RAI Working Group in coordination with ICMR-NIRDH. Earlier, she worked as an innovation consultant at Capgemini, focused on AI-driven sustainable supply chain solutions.

View Bio
Nishtha Mahendru

Nishtha Mahendru

close

Nishtha Mahendru is Technical Consultant, AI Innovation at Project Concern International India, where she develops AI-enabled tools for infectious disease control. She holds an M.Tech in Biomedical Engineering from IIT Delhi. Previously, as Assistant Manager for Responsible AI & Strategy at MicroSave Consulting, she co-authored India’s National Responsible AI Development Framework and led the national RAI Working Group in coordination with ICMR-NIRDH. Earlier, she worked as an innovation consultant at Capgemini, focused on AI-driven sustainable supply chain solutions.

Priya Balasubramaniam

Dr. Priya Balasubramaniam is a public health scientist with 20 years’ experience strengthening health systems in Asia and Africa. She is Director of the Centre for Sustainable Health Innovations and Senior Scientist at the Public Health Foundation of India. She leads south-south collaboratives applying AI to primary care in mixed health systems, grounded in user-design research with communities, and works on how these tools are evaluated, governed and stewarded so they narrow rather than widen inequities. A founding member of the LEAD (Leadership in Enhancing Antimicrobial Discovery) coalition, she co-leads OASIS, the MIT Trinity Challenge-winning One Health antibiotic stewardship consortium.

View Bio
Priya Balasubramaniam

Priya Balasubramaniam

close

Dr. Priya Balasubramaniam is a public health scientist with 20 years’ experience strengthening health systems in Asia and Africa. She is Director of the Centre for Sustainable Health Innovations and Senior Scientist at the Public Health Foundation of India. She leads south-south collaboratives applying AI to primary care in mixed health systems, grounded in user-design research with communities, and works on how these tools are evaluated, governed and stewarded so they narrow rather than widen inequities. A founding member of the LEAD (Leadership in Enhancing Antimicrobial Discovery) coalition, she co-leads OASIS, the MIT Trinity Challenge-winning One Health antibiotic stewardship consortium.

Rado Andrian

Rado Andrian spearheads global initiatives at HealthAI to advance AI governance, regulation, and ethical deployment in healthcare. With over 20 years of experience driving transformative digital health and AI innovations in the Healthcare and Life Sciences sectors, Rado is renowned for his hands-on expertise in digital strategy, solution-building, and forging impactful partnerships. His work fosters collaboration, creates pragmatic toolkits, and ensures AI’s safe, compliant, and responsible integration into healthcare systems. Beyond HealthAI, Rado is a recognized thought leader in the Swiss and international Digital Health Innovation ecosystem, championing Value-Based Healthcare (VBHC) and the “5Ps of Medicine”—Personalized, Predictive, Preventive, Participatory, and Populational—through strategic cooperation between patients, providers, pharma, payers, and policymakers.

View Bio
Rado Andrian

Rado Andrian

close

Rado Andrian spearheads global initiatives at HealthAI to advance AI governance, regulation, and ethical deployment in healthcare.
With over 20 years of experience driving transformative digital health and AI innovations in the Healthcare and Life Sciences sectors, Rado is renowned for his hands-on expertise in digital strategy, solution-building, and forging impactful partnerships. His work fosters collaboration, creates pragmatic toolkits, and ensures AI’s safe, compliant, and responsible integration into healthcare systems.
Beyond HealthAI, Rado is a recognized thought leader in the Swiss and international Digital Health Innovation ecosystem, championing Value-Based Healthcare (VBHC) and the “5Ps of Medicine”—Personalized, Predictive, Preventive, Participatory, and Populational—through strategic cooperation between patients, providers, pharma, payers, and policymakers.

Raymond Chua

Adjunct Professor (Dr) Raymond Chua is the Chief Executive Officer of the Health Sciences Authority of Singapore, responsible for safeguarding and advancing public health through securing the national blood supply, administering national justice through its forensic medicine and scientific testing capabilities, and regulating health products. He is also the Deputy Director-General of Health (Health Regulation) at the Ministry of Health, overseeing the regulations of healthcare services and information. Raymond Chua holds adjunct professorships at the NUS Saw Swee Hock School of Public Health, and the Centre of Regulatory Excellence in Duke-NUS. He also holds a Bachelor of Medicine and Bachelor of Surgery from NUS Yong Loo Lin School of Medicine, a Master of Science in Public Health from the London School of Hygiene and Tropical Medicine and a Master of Business Administration from the University of Nottingham.

View Bio
Raymond Chua

Raymond Chua

close

Adjunct Professor (Dr) Raymond Chua is the Chief Executive Officer of the Health Sciences Authority of Singapore, responsible for safeguarding and advancing public health through securing the national blood supply, administering national justice through its forensic medicine and scientific testing capabilities, and regulating health products. He is also the Deputy Director-General of Health (Health Regulation) at the Ministry of Health, overseeing the regulations of healthcare services and information. Raymond Chua holds adjunct professorships at the NUS Saw Swee Hock School of Public Health, and the Centre of Regulatory Excellence in Duke-NUS. He also holds a Bachelor of Medicine and Bachelor of Surgery from NUS Yong Loo Lin School of Medicine, a Master of Science in Public Health from the London School of Hygiene and Tropical Medicine and a Master of Business Administration from the University of Nottingham.

Rebecca K. Ivic

Rebecca K. Ivic, Ph.D., is a Professor of Health Communication, Executive Editor and incoming Editor-in-Chief of the Journal of Health Communication, and Commissioner for the Nature Medicine Commission on Quality Health Information for All. Her research bridges public health and computational social science, with a focus on health information quality, information integrity and health literacy, digital media and health literate AI. She leads the development of global quality health indicators to guide policy and governance with attention to under resourced and low-income countries and works with global organizations, governments, and community health to strengthen trustworthy, usable, and equitable health information.

View Bio
Rebecca K. Ivic

Rebecca K. Ivic

close

Rebecca K. Ivic, Ph.D., is a Professor of Health Communication, Executive Editor and incoming Editor-in-Chief of the Journal of Health Communication, and Commissioner for the Nature Medicine Commission on Quality Health Information for All. Her research bridges public health and computational social science, with a focus on health information quality, information integrity and health literacy, digital media and health literate AI. She leads the development of global quality health indicators to guide policy and governance with attention to under resourced and low-income countries and works with global organizations, governments, and community health to strengthen trustworthy, usable, and equitable health information.

Ricardo Baptista Leite

Dr. Ricardo Baptista Leite is a Portuguese-Canadian medical doctor trained in infectious diseases with extensive experience in global health, health systems and science-based policymaking. Prior to his current role as CEO of ‘HealthAI – The Global Agency for Responsible AI in Health’ in Geneva, Dr. Ricardo served four terms as a Member of Parliament in Portugal on both health and foreign affairs committees. Ricardo is a city councillor in Sintra and previously served as Deputy Mayor of Cascais. He is the founder and President of the ‘UNITE Parliamentarians Network for Global Health’, a network of current and former policymakers from 110 countries. With more than 15 years of academic experience, he is Chair of the Board of the Harvard-Charité Global Health Policy Lab, based in Berlin, and Chair of the Centre for Global Health at NOVA University Information Management and Data Science School in Lisbon. He completed postgraduate studies at Johns Hopkins University, Harvard Kennedy School of Government and Harvard Medical School. Previously, Dr Baptista Leite worked as a practising physician in the Portuguese National Health Service for several years, including an internship at the World Health Organization. More recently, he served as a medical volunteer both during the COVID pandemic in his hometown hospital in Portugal for over a year and as part of a humanitarian mission at the Lviv Regional Hospital in Ukraine during the first summer after the beginning of the war.

View Bio
Ricardo Baptista Leite

Ricardo Baptista Leite

close

Dr. Ricardo Baptista Leite is a Portuguese-Canadian medical doctor trained in infectious diseases with extensive experience in global health, health systems and science-based policymaking. Prior to his current role as CEO of ‘HealthAI – The Global Agency for Responsible AI in Health’ in Geneva, Dr. Ricardo served four terms as a Member of Parliament in Portugal on both health and foreign affairs committees. Ricardo is a city councillor in Sintra and previously served as Deputy Mayor of Cascais.
He is the founder and President of the ‘UNITE Parliamentarians Network for Global Health’, a network of current and former policymakers from 110 countries. With more than 15 years of academic experience, he is Chair of the Board of the Harvard-Charité Global Health Policy Lab, based in Berlin, and Chair of the Centre for Global Health at NOVA University Information Management and Data Science School in Lisbon. He completed postgraduate studies at Johns Hopkins University, Harvard Kennedy School of Government and Harvard Medical School. Previously, Dr Baptista Leite worked as a practising physician in the Portuguese National Health Service for several years, including an internship at the World Health Organization.
More recently, he served as a medical volunteer both during the COVID pandemic in his hometown hospital in Portugal for over a year and as part of a humanitarian mission at the Lviv Regional Hospital in Ukraine during the first summer after the beginning of the war.

Rose Nakasi

Dr. Rose Nakasi is an AI researcher, Lecturer at Makerere University, and Head of the Makerere AI Health Lab. She leads research applying AI to affordable healthcare solutions in low- and middle-income countries. She contributes to Uganda’s national AI strategy and the WHO Global Initiative on Artificial Intelligence for Health.

View Bio
Rose Nakasi

Rose Nakasi

close

Dr. Rose Nakasi is an AI researcher, Lecturer at Makerere University, and Head of the Makerere AI Health Lab. She leads research applying AI to affordable healthcare solutions in low- and middle-income countries. She contributes to Uganda’s national AI strategy and the WHO Global Initiative on Artificial Intelligence for Health.

Roxana Salehi

Roxana Salehi, PhD, is a strategic advisor for complex health initiatives, an author, and founder of Vitus Consulting, with over 15 years of global experience addressing complex global health challenges. She has led multi-country initiatives across hospital, community health, and global health settings in Canada, Ghana, Malawi, Pakistan, Spain, and the Caribbean. Her expertise includes health systems research, implementation science, AI-enabled healthcare, and program evaluation, including economic evaluation. She works across disciplines to align clinicians, patients, policymakers, funders, and technologists around shared goals. She is Co-Chair of HealthAI’s Working Group on AI Evaluation and Validation in Healthcare.

View Bio
Roxana Salehi

Roxana Salehi

close

Roxana Salehi, PhD, is a strategic advisor for complex health initiatives, an author, and founder of Vitus Consulting, with over 15 years of global experience addressing complex global health challenges. She has led multi-country initiatives across hospital, community health, and global health settings in Canada, Ghana, Malawi, Pakistan, Spain, and the Caribbean. Her expertise includes health systems research, implementation science, AI-enabled healthcare, and program evaluation, including economic evaluation. She works across disciplines to align clinicians, patients, policymakers, funders, and technologists around shared goals. She is Co-Chair of HealthAI’s Working Group on AI Evaluation and Validation in Healthcare.

Simona Dobre

Simona Dobre, PhD, is an AI strategy and governance professional at the Swiss Tropical and Public Health Institute (Swiss TPH), with a multidisciplinary background spanning artificial intelligence, automatic control, computer science, and health. Her work focuses on the responsible and practical adoption of AI in global health, including digital health and health-financing systems. She has contributed to initiatives such as openIMIS, including AI-based health insurance claims adjudication, and helped develop digital health solutions, while facilitating training and dialogue on responsible and ethical AI. Her work bridges technical AI expertise with questions of governance, equity, accountability, and implementation.

View Bio
Simona Dobre

Simona Dobre

close

Simona Dobre, PhD, is an AI strategy and governance professional at the Swiss Tropical and Public Health Institute (Swiss TPH), with a multidisciplinary background spanning artificial intelligence, automatic control, computer science, and health. Her work focuses on the responsible and practical adoption of AI in global health, including digital health and health-financing systems. She has contributed to initiatives such as openIMIS, including AI-based health insurance claims adjudication, and helped develop digital health solutions, while facilitating training and dialogue on responsible and ethical AI. Her work bridges technical AI expertise with questions of governance, equity, accountability, and implementation.

Ummi Musa Umar

Ummi Musa Umar is a Public Health and Radiotherapy professional based in Nigeria, with over ten years of experience in frontline healthcare delivery, cancer and NCD prevention, and digital health innovation. She is Founder and Executive Director of Call Off Cancer Initiative and Uhealth Africa, and serves on Nigeria’s National Technical Working Group on NCDs and National Taskforce for Cervical Cancer Elimination. A recognized voice in global AI-in-health governance, she hosts the Uhealth Digital Health and AI Series, convening intercontinental dialogue on responsible AI adoption for low- and middle-income countries.

View Bio
Ummi Musa Umar

Ummi Musa Umar

close

Ummi Musa Umar is a Public Health and Radiotherapy professional based in Nigeria, with over ten years of experience in frontline healthcare delivery, cancer and NCD prevention, and digital health innovation. She is Founder and Executive Director of Call Off Cancer Initiative and Uhealth Africa, and serves on Nigeria’s National Technical Working Group on NCDs and National Taskforce for Cervical Cancer Elimination. A recognized voice in global AI-in-health governance, she hosts the Uhealth Digital Health and AI Series, convening intercontinental dialogue on responsible AI adoption for low- and middle-income countries.

Veerapandian Ganesan

Shri G. Veerapandian, IAS, a 2009-batch Andhra Pradesh cadre officer, currently serves as Secretary to Government, Health, Medical & Family Welfare, Government of Andhra Pradesh. With extensive experience in public administration, he has held key leadership positions including Commissioner, Health & Family Welfare & Mission Director, NHM; Commissioner of Civil Supplies & Ex-Officio Secretary to Government; Vice Chairman & Managing Director, AP State Civil Supplies Corporation; CEO, SERP; and Special Secretary, Agriculture & Marketing.

View Bio
Veerapandian Ganesan

Veerapandian Ganesan

close

Shri G. Veerapandian, IAS, a 2009-batch Andhra Pradesh cadre officer, currently serves as Secretary to Government, Health, Medical & Family Welfare, Government of Andhra Pradesh.
With extensive experience in public administration, he has held key leadership positions including Commissioner, Health & Family Welfare & Mission Director, NHM; Commissioner of Civil Supplies & Ex-Officio Secretary to Government; Vice Chairman & Managing Director, AP State Civil Supplies Corporation; CEO, SERP; and Special Secretary, Agriculture & Marketing.

Accomodation

Special Rates for GGF Participants

Participants to the HealthAI Global Governance Forum 2026 can book rooms at an exclusive rate at The Gate London City hotel, about 5 minutes on foot (0.2 miles) from the GGF venue. Click on the link below to access our special room rate.

Enjoy an Exclusive 22% Discount on Your Stay at The Gate London City

 

The Gate London City
Transportation & Transit

Hotel Address: The Gate London City, 41 White Church Ln, London E1 7QR

Nearest Tube: Aldgate East (District & Hammersmith & City lines) is a 3-min walk from the hotel.

Venue Address: Events @ No 6, 6 Alie St, London E1 8QT

Walking hotel ↔ venue: 10–12 minutes (about 0.6 miles / 1 km) via Whitechapel Road and Commercial Road; well‑lit, main roads.

Best public‑transport option to Whitechapel/Aldgate East

Heathrow (LHR): Elizabeth line direct to Whitechapel – 45–50 min – £15.50

Gatwick (LGW): Thameslink to London Bridge, then Jubilee line to Aldgate East – 60–75 min – £12–£16

Stansted (STN): National Express/other coach to Whitechapel or Liverpool Street + short Tube – 60–75 min – £8–£12

Luton (LTN): Thameslink to Farringdon/London Bridge + Tube, or coach to Victoria + Tube – 75–90 min – £12–£18

London City (LCY): DLR to Aldgate East – 20–30 min – £3–£5 (DLR)

Taxis / ride‑hail (approximate, one‑way, to hotel):

  • Heathrow: £55–£75
  • Gatwick: £60–£80
  • Stansted/Luton: £65–£90
  • London City: £20–£30

(Prices vary by time of day, traffic, and provider; always use licensed black cabs or reputable apps.)

Getting around London:

Use contactless bank cards (Visa/Mastercard/Amex) or mobile wallets (Apple Pay/Google Pay) to tap in/out on Tube, bus, DLR, Overground, and Elizabeth line.

Oyster cards are an alternative (£7 deposit, refundable); Visitor Oyster cards can be ordered in advance.

Cash is not accepted on buses; contactless/Oyster is strongly recommended.

Visa Requirements

Whether you need a visa depends on your nationality. Many visitors attend under the Standard Visitor route (which permits conference attendance).

  • Check if you need a visa and apply online here: GOV.UK – Check if you need a UK visa

  • Standard Visitor visa (if required): typically up to 6 months; fee ~£135.

  • Electronic Travel Authorisation (ETA): required for some non‑visa nationals (e.g., many European, US, Australian passport holders may need an ETA depending on final rules). Check the official guidance before travel.

  • If you need an invitation letter for your visa application, contact the HealthAI events team in advance.

Bring: passport, invitation/registration confirmation, proof of accommodation, and evidence of funds/return travel if requested by border officers.

Health Requirements

No special vaccinations are mandated for entry to the UK, but you should be up to date on routine vaccines (MMR, diphtheria‑tetanus‑polio, etc.)

  • Recommended before travel: ensure routine vaccines are current; consider hepatitis A and typhoid if you may eat outside typical tourist settings.

  • Polio: a one‑time adult booster is advised for travelers to the UK if your last dose was many years ago.

  • COVID‑19: stay up to date per your national guidance.

  • For country‑specific advice, see: NHS – Travel vaccinations and TravelHealthPro – United Kingdom.

If you take prescription medicines, carry them in original packaging with a copy of your prescription.

Security Information

London is generally safe, but use big‑city precautions:

  • Pickpockets: keep phones, wallets, and bags secure and in sight; avoid back pockets and unattended items.

  • ATMs: cover the keypad, check for tampering, and don’t share your PIN.

  • Taxis: use licensed black cabs or reputable apps; avoid unmarked cars.

  • Night travel: stick to well‑lit main roads; avoid deserted tunnels/underpasses; travel in groups when possible.

  • Unattended bags: never leave luggage unattended in stations, hotels, or public venues (this can trigger security alerts).

  • Emergencies: call 999 (or 112) for police/ambulance/fire; 101 for non‑urgent police matters.

Further tips: Visit London – Staying safe

Weather in November

Expect cool, changeable autumn weather with a real chance of rain.

  • Average temperatures: daytime ~10–11°C (50–52°F); nights ~4–6°C (39–43°F)

  • Rainfall: ~60–70 mm over the month; around 8–11 rainy days.

  • Daylight: short days; plan indoor alternatives and allow extra time for travel.

What to pack: waterproof jacket or umbrella, warm layers, comfortable closed shoes, and a scarf/gloves for evenings.

General Information
  • Electricity: 230V, 50Hz; Type G (three rectangular pins). Travelers from 100–127V countries need a voltage converter for non‑dual‑voltage devices; most phone/laptop chargers are dual‑voltage (check the label).

  • Time zone: GMT (UTC+0); in November the UK is on GMT (clocks change back from BST late October).

  • Payments: contactless cards and mobile wallets are widely accepted; cash is less commonly needed but still useful for small vendors.

  • Water: tap water is safe to drink throughout London.

  • Language: English is the main language; signage is clear on public transport.

  • Mobile data: check roaming charges with your provider; consider an eSIM/local SIM if needed.

  • Accessibility: most Tube stations have step‑free access information online; plan ahead if you require it.

If you need more detail on any topic, visit: tripzoria.com/united-kingdom.

Safe travels, and see you in London for the Global Governance Forum.

Special Rates for GGF Participants

Event Venue

The GGF will take place at Events @ No 6 in London

Events @ No 6 is located at 6 Alie Street, London E1 8QT, United Kingdom, close to Aldgate and Aldgate East Underground stations.

Detailed timings, accessibility information and travel guidance will be shared with confirmed participants before the Forum.

The GGF will take place at Events @ No 6 in London

Our Strategic Partners

The HealthAI Global Governance Forum 2026 is organized thanks to the meaningful contribution by our two strategic partners, The Health Foundation and the United Kingdom’s Medicines & Healthcare products Regulatory Agency (MHRA).

Road to Geneva 2027

For many decades, Geneva has been a place where nations, international organizations, civil society, academia and the private sector have come together to address humanity’s most pressing challenges.

Led by the Federal Department of the Environment, Transport, Energy and Communications (DETEC), in collaboration with the Federal Department of Foreign Affairs (FDFA), the Summit will build on Switzerland’s commitment to inclusive and multistakeholder AI governance.

The Geneva AI Summit 2027 is to be held on the theme of ‘Bridging Innovation and Trust’ with the focus set on two strategic priorities: AI as a driver of prosperity and progress for all and fostering trustworthy, responsible and safe use of AI.

 

The HealthAI Global Governance Forum is an official pre-event of the Geneva AI Summit 2027

Highlights of the HealthAI GGF 2025 in Nairobi

Play video

Newsletter

    This feature
    is currently locked

    close

    You need to be logged in

    Sign in to continue and unlock this feature.